MKI67 and familial pancreatic carcinoma: In conclusion, proliferative markers including Ki‐67, PCNA, PHH3 and Cyclin D1 have demonstrated promise as predictive and prognostic biomarkers in the context of pancreatic cancer chemotherapy.